Search

everythinglearnresearchcommunity

for

Search:↓

Thyroid and reproductive hormones, BMI, and excess hair are linked in Iraqi women with PCOS.

Women have a higher DHT/testosterone ratio than men, possibly due to gut bacteria activity.

The skin's ability to produce hormones is linked to various skin conditions, and better understanding this process could lead to new treatments.

Genes and hormones cause hair loss, with four genes contributing equally.

Hormones and their receptors, especially androgens, play a key role in hair growth and disorders like baldness.

Intersex frogs have different brain gene activity related to sex and thyroid hormones.

Hormone imbalances can cause skin diseases, and understanding these links is important for diagnosis and treatment.

Sebaceous glands in our skin, developing during pregnancy and active in puberty, produce sebum for skin lubrication, temperature control, and fighting germs, also help in hormone regulation, and their dysfunction can cause conditions like acne and hair loss.

The woman was misdiagnosed with Graves Disease, leading to incorrect treatment, while she actually had Pituitary Resistance to Thyroid Hormone.

Lupus can be a rare cause of high calcium levels in the blood.

Women with Polycystic Ovary Syndrome (PCOS) have a higher risk of developing type 2 diabetes due to insulin resistance.

Blocking CRF1 receptors improved male hormone levels and reduced testicular tumor size in men with a specific adrenal condition.

Male hormones like testosterone may make COVID-19 worse, and testing for sensitivity to these hormones could help predict how severe a patient's symptoms might be. Treatments that reduce these hormones are being explored.

Hormones significantly affect hair growth and loss, requiring personalized treatment.

Certain gene changes and hormone levels are linked to female hair loss.

Females have higher estrogen receptor levels in hair than males, and these levels decrease in white hair compared to black hair.

Estrogens can improve skin aging but carry risks; more research is needed on safer treatments.

Male and female skin differ due to hormones, affecting conditions like hair loss, acne, and skin cancer, and suggesting a need for gender-specific treatments.

Male hormones affect COVID-19 severity and certain drugs targeting these hormones could help reduce the risk.

C60 fullerenes can alter protein function and may help develop new disease inhibitors.

The hairless gene is crucial for hair health, and its mutations cause hair loss.

Spironolactone is safe for treating female hair loss, but the safety of other drugs is uncertain.

Hormone replacement therapy may improve hair growth in the frontal hairline of postmenopausal women with hair loss.

Thyroid disease can cause hair loss and treating thyroid problems might help with hair disorders.

Stress-related substance P may lead to hair loss and negatively affect hair growth.

GLP-1 receptor agonists, like Dulaglutide, Liraglutide, and Semaglutide, have potential benefits beyond the pancreas, including neuroprotection, pain suppression, cardiovascular protection, obesity management, and cancer treatment, but there are concerns about pancreatitis and pancreatic cancer risks.

Brain hormones significantly affect hair color and could potentially be used to prevent or reverse grey hair.

Flutamide combined with an LHRH agonist effectively inhibits prostate growth, suggesting it could treat prostate cancer.

Lower MC2R expression may contribute to alopecia areata.

COVID-19 may harm male fertility and damage the reproductive system.